24.8 C
New York
Saturday, June 6, 2026

Tag: imaging

Top Los Angeles Oral and Maxillofacial Surgeon Dr. David Salehani Enhances Genioplasty and Corrective Jaw Surgery with Virtual Surgical Planning

Dr. David Salehani, a top Los Angeles oral and maxillofacial surgeon, is revolutionizing chin and jaw surgeries using Virtual Surgical Planning (VSP), a 3D planning...

MicroCloud Hologram Inc. Announces Significant Returns from Crypto Asset Strategic Investment: Cumulative Investment Returns Reach $40.45 Million

SHENZHEN, China, Aug. 11, 2025 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), a technology service provider, announced that the company's...

Cox Automotive Advances AI-Powered Dealership Innovation with New vAuto and UVeye Integration

Integration marks the latest milestone in Cox Automotive's continued investment in delivering the industry's most complete view of every vehicle across retail and wholesale. ATLANTA...

NextVision Reports Continued Rapid Growth and Record Results for Q2 2025

Company revenues grew by approximately 32%, reaching about $37 millionGross profit increased by approximately 32%, reaching $26.5 millionNet profit rose by approximately 46%, reaching...

HistoIndex Marks Another Step Forward with FibroSIGHT™ Plus: Introducing AI-based Quantitative Analysis in Fibrosis Assessment

SINGAPORE, Aug. 10, 2025 /PRNewswire/ -- HistoIndex, a pioneering leader in digital pathology solutions for chronic liver disease, has announced the launch of FibroSIGHT™...

HistoIndex Marks Another Step Forward with FibroSIGHT™ Plus: Introducing AI-based Quantitative Analysis in Fibrosis Assessment

SINGAPORE, Aug. 11, 2025 /PRNewswire/ -- HistoIndex, a pioneering leader in digital pathology solutions for chronic liver disease, has announced the launch of FibroSIGHT™...

HistoIndex Marks Another Step Forward with FibroSIGHT™ Plus: Introducing AI-based Quantitative Analysis in Fibrosis Assessment

SINGAPORE, Aug. 11, 2025 /PRNewswire/ -- HistoIndex, a pioneering leader in digital pathology solutions for chronic liver disease, has announced the launch of FibroSIGHT™...

RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA¹ and Revises Upwards 2025 Financial Guidance Ranges

LOS ANGELES, Aug. 10, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 405 owned and operated outpatient imaging centers, today reported financial results for its second quarter of 2025.

Dover Increases Dividend

DOWNERS GROVE, Ill., Aug. 8, 2025 /PRNewswire/ -- The Board of Directors of Dover Corporation (NYSE: DOV) today increased its quarterly cash dividend to...

LionCare: The Future of Wellness with Terahertz Technology for Restful Sleep and Healing in 2025

Experience Groundbreaking Sleep and Cellular Support Backed by Terahertz Innovation, Trusted by Wellness Experts in 2025
Experience Groundbreaking Sleep and Cellular Support Backed by Terahertz Innovation, Trusted by Wellness Experts in 2025

MarketsandMarkets’ 360Quadrants Recognizes Top Startups and SMEs in the Hospital Information System Quadrant Report 2025

DELRAY BEACH, Fla., Aug. 8, 2025 /PRNewswire/ -- 360Quadrants has released its latest Hospital Information System Startups/SMEs, 2025, recognizing key players, including both global...

Implantica announces second publication of groundbreaking 5-year results from the landmark RefluxStop® clinical study

VADUZ, Liechtenstein, Aug. 7, 2025 /PRNewswire/ -- Implantica AG (publ), a leading medtech company pioneering advanced implantable medical technologies, today announced the second peer-reviewed...

Intas Pharmaceuticals and Accord BioPharma Become One of the Largest Global Suppliers of Pegfilgrastim with Acquisition of UDENYCA®

AHMEDABAD, India, Aug. 7, 2025 /PRNewswire/ -- Intas Pharmaceuticals in collaboration with its global subsidiaries operating under the Accord brand, has solidified its position as...

Urothelial Carcinoma Market Set to Expand During the Forecast Period (2025-2034) Amid Rising Incidence and Evolving Therapeutic Landscape | DelveInsight

The dynamics of the urothelial carcinoma market are anticipated to change due to the demand for innovative therapies, particularly in chemotherapy and immunotherapy, and...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsImaging